---
title: "兆科眼科-B：贝美前列素滴眼液 (晶贝清®) 获国家药监局批准上市"
description: "兆科眼科-B 宣布，其研发的抗青光眼药物贝美前列素滴眼液 (晶贝清®) 已获得国家药监局批准上市。这是中国首款不含防腐剂的单剂量贝美前列素滴眼液，旨在降低开角型青光眼及高眼压症患者的眼压，改善患者舒适感，并提高用药依从性。"
type: "news"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/214732882.md"
published_at: "2024-09-19T22:27:03.000Z"
---

# 兆科眼科-B：贝美前列素滴眼液 (晶贝清®) 获国家药监局批准上市

> 兆科眼科-B 宣布，其研发的抗青光眼药物贝美前列素滴眼液 (晶贝清®) 已获得国家药监局批准上市。这是中国首款不含防腐剂的单剂量贝美前列素滴眼液，旨在降低开角型青光眼及高眼压症患者的眼压，改善患者舒适感，并提高用药依从性。

智通财经 APP 讯，兆科眼科-B(06622) 发布公告，由公司研发生产的抗青光眼药物贝美前列素滴眼液 (晶贝清®) 获得国家药品监督管理局 (国家药监局) 批准上市。

贝美前列素滴眼液 (晶贝清®) 乃中国首款不含防腐剂的单剂量贝美前列素滴眼液，用于降低开角型青光眼及高眼压症患者的眼压。该款药物不含防腐剂，避免青光眼患者因长期使用含有防腐剂的药物而导致眼表受损。与此同时，该款药物亦有助于改善患者于治疗期间的舒适感，减少对防腐剂相关敏感的风险。其每日一次用药频率亦有助于提高患者依从性。

### Related Stocks

- [06622.HK - 兆科眼科-B](https://longbridge.com/zh-CN/quote/06622.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Saudi CMA Approves Public Offering Of Namaa Waqf Fund | SAUDI CMA :APPROVES PUBLIC OFFERING OF NAMAA WAQF FUND | [Link](https://longbridge.com/zh-CN/news/276066018.md) |
| Why has Kris Jenner's $13.5 million 'Keeping Up With the Kardashians' house sat on the market for over a year? | Kris Jenner's $13.5 million mansion, featured in "Keeping Up With the Kardashians," has been on the market for over a ye | [Link](https://longbridge.com/zh-CN/news/276110851.md) |
| Powerful storm in Redding bringing high wind, heavy rain, snow | A powerful winter storm is impacting Redding and Shasta County, bringing strong winds, heavy rain, and potential snow. W | [Link](https://longbridge.com/zh-CN/news/276082455.md) |
| French police raid Arab World Institute in Epstein-linked probe into Jack Lang | PARIS, Feb 16 (Reuters) - French police on Monday searched the Arab World Institute in Paris in connection with an inves | [Link](https://longbridge.com/zh-CN/news/276051725.md) |
| Greenland's west coast posts warmest January on record | Greenland's capital Nuuk recorded its warmest January ever, surpassing a 109-year-old record, with an average temperatur | [Link](https://longbridge.com/zh-CN/news/276050659.md) |

---

> **免责声明**：本文内容仅供参考，不构成任何投资建议。